Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SCIENCE GROUP PLC Board/Management Information 2021

Aug 10, 2021

7903_nav_2021-08-10_cd5cd3c2-fdcb-444e-84e1-33a37fb918f8.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 0719I

Science Group PLC

10 August 2021

10 August 2021

Board Update

Science Group plc (the "Company") together with its subsidiaries ("Science Group" or the "Group") announces that, following its announcement on 12 July 2021, Mr Jon Brett, previously Group Financial Controller, has been appointed Acting Finance Director and to the Science Group Board.

Mr Brett trained with Deloitte LLP and qualified in 2004. He joined Science Group in March 2020.

End

Science Group plc                                                                                             Tel : +44 (0) 1223 875200

Sarah Cole, Company Secretary                                                                      www.sciencegroup.com 

Stifel Nicolaus Europe Limited (Nominated Adviser & Broker)              Tel : +44 (0) 20 7710 7600

Nick Adams, Alex Price

Liberum Capital Limited (Joint Broker)                                                        Tel: +44 (0) 20 3100 2000

Neil Patel, Cameron Duncan

Regulatory disclosures

In accordance with Schedule 2(g) of the AIM Rules, Jonathan (Jon) Brett (aged 41) holds or has held in the past 5 years the following directorships and partnerships:

Current Within the past 5 years
Ditton Walk Property Management Company Limited None

Mr Brett does not hold any shares in the Company but holds options over 10,000 ordinary shares.

Save for the disclosures above, there are no further disclosures to be made in accordance with AIM Rule 17 and Schedule 2(g) of the AIM Rules.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAEAXPNEFFFEFA